Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years
Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).
Representatives from a dozen global organizations and as many countries launched a new collaboration with the National Eye Institute aimed at advancing vision research and eye heath globally
To better understand eye health care needs of the future, the National Eye Institute convened a panel of experts April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology.
An inexpensive, smartphone-based camera can help doctors identify premature infants needing treatment for retinopathy of prematurity (ROP), according to a new study funded by the National Eye Institute (NEI).
Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.
The National Eye Institute has published "Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI town hall report."
A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.